Pfizer, BioNTech to Jointly Develop Shingles Vaccine

Published by
The Street

By Dan Weil The collaboration will be based on mRNA technology and builds on Pfizer and BioNTech’s successful effort to produce a Covid vaccine. Pfizer (PFE) – Get Pfizer Inc. Report and BioNTech (BNTX) – Get BioNTech SE Report on Monday said they would jointly develop what they said could be the first mRNA-based vaccine to prevent shingles. “The collaboration builds on the companies’ success in developing the first approved and most widely used mRNA vaccine to help prevent Covid-19,” the pharmaceutical titans said. Messenger ribonucleic acid is a type of RNA that is necessary for protein prod…

Read More